Cargando…

Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance

The discovery that obesity promotes macrophage accumulation in visceral fat led to the emergence of a new field of inquiry termed “immunometabolism”. This broad field of study was founded on the premise that inflammation and the corresponding increase in macrophage number and activity was a patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgibbons, Timothy P., Czech, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803808/
https://www.ncbi.nlm.nih.gov/pubmed/26847458
http://dx.doi.org/10.1007/s00109-016-1385-4
_version_ 1782422910489591808
author Fitzgibbons, Timothy P.
Czech, Michael P.
author_facet Fitzgibbons, Timothy P.
Czech, Michael P.
author_sort Fitzgibbons, Timothy P.
collection PubMed
description The discovery that obesity promotes macrophage accumulation in visceral fat led to the emergence of a new field of inquiry termed “immunometabolism”. This broad field of study was founded on the premise that inflammation and the corresponding increase in macrophage number and activity was a pathologic feature of metabolic diseases. There is abundant data in both animal and human studies that supports this assertation. Established adverse effects of inflammation in visceral fat include decreased glucose and fatty acid uptake, inhibition of insulin signaling, and ectopic triglyceride accumulation. Likewise, in the atherosclerotic plaque, macrophage accumulation and activation results in plaque expansion and destabilization. Despite these facts, there is an accumulating body of evidence that macrophages also have beneficial functions in both atherosclerosis and visceral obesity. Potentially beneficial functions that are common to these different contexts include the regulation of efferocytosis, lipid buffering, and anti-inflammatory effects. Autophagy, the process by which cytoplasmic contents are delivered to the lysosome for degradation, is integral to many of these protective biologic functions. The macrophage utilizes autophagy as a molecular tool to maintain tissue integrity and homeostasis at baseline (e.g., bone growth) and in the face of ongoing metabolic insults (e.g., fasting, hypercholesterolemia, obesity). Herein, we highlight recent evidence demonstrating that abrogation of certain macrophage functions, in particular autophagy, exacerbates both atherosclerosis and obesity-induced insulin resistance. Insulin signaling through mammalian target of rapamycin (mTOR) is a crucial regulatory node that links nutrient availability to macrophage autophagic flux. A more precise understanding of the metabolic substrates and triggers for macrophage autophagy may allow therapeutic manipulation of this pathway. These observations underscore the complexity of the field “immunometabolism”, validate its importance, and raise many fascinating and important questions for future study.
format Online
Article
Text
id pubmed-4803808
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48038082016-04-09 Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance Fitzgibbons, Timothy P. Czech, Michael P. J Mol Med (Berl) Review The discovery that obesity promotes macrophage accumulation in visceral fat led to the emergence of a new field of inquiry termed “immunometabolism”. This broad field of study was founded on the premise that inflammation and the corresponding increase in macrophage number and activity was a pathologic feature of metabolic diseases. There is abundant data in both animal and human studies that supports this assertation. Established adverse effects of inflammation in visceral fat include decreased glucose and fatty acid uptake, inhibition of insulin signaling, and ectopic triglyceride accumulation. Likewise, in the atherosclerotic plaque, macrophage accumulation and activation results in plaque expansion and destabilization. Despite these facts, there is an accumulating body of evidence that macrophages also have beneficial functions in both atherosclerosis and visceral obesity. Potentially beneficial functions that are common to these different contexts include the regulation of efferocytosis, lipid buffering, and anti-inflammatory effects. Autophagy, the process by which cytoplasmic contents are delivered to the lysosome for degradation, is integral to many of these protective biologic functions. The macrophage utilizes autophagy as a molecular tool to maintain tissue integrity and homeostasis at baseline (e.g., bone growth) and in the face of ongoing metabolic insults (e.g., fasting, hypercholesterolemia, obesity). Herein, we highlight recent evidence demonstrating that abrogation of certain macrophage functions, in particular autophagy, exacerbates both atherosclerosis and obesity-induced insulin resistance. Insulin signaling through mammalian target of rapamycin (mTOR) is a crucial regulatory node that links nutrient availability to macrophage autophagic flux. A more precise understanding of the metabolic substrates and triggers for macrophage autophagy may allow therapeutic manipulation of this pathway. These observations underscore the complexity of the field “immunometabolism”, validate its importance, and raise many fascinating and important questions for future study. Springer Berlin Heidelberg 2016-02-04 2016 /pmc/articles/PMC4803808/ /pubmed/26847458 http://dx.doi.org/10.1007/s00109-016-1385-4 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Fitzgibbons, Timothy P.
Czech, Michael P.
Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title_full Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title_fullStr Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title_full_unstemmed Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title_short Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
title_sort emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803808/
https://www.ncbi.nlm.nih.gov/pubmed/26847458
http://dx.doi.org/10.1007/s00109-016-1385-4
work_keys_str_mv AT fitzgibbonstimothyp emergingevidenceforbeneficialmacrophagefunctionsinatherosclerosisandobesityinducedinsulinresistance
AT czechmichaelp emergingevidenceforbeneficialmacrophagefunctionsinatherosclerosisandobesityinducedinsulinresistance